Low tumor cell density environment yields survival advantage of tumor cells exposed to MTX in vitro
- 1 January 2005
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1721 (1-3) , 98-106
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogsCancer Chemotherapy and Pharmacology, 2002
- Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- ApoptosisCell, 2002
- Overexpression of folate binding protein α is one of the mechanism explaining the adaptation of HT29 cells to high concentration of methotrexateCancer Letters, 2001
- Resistance to high concentrations of methotrexate and 5-fluorouracil of differentiated HT-29 colon-cancer cells is restricted to cells of enterocytic phenotypeInternational Journal of Cancer, 1998
- Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damageBritish Journal of Cancer, 1997
- Expression of Fragile Sites Triggers Intrachromosomal Mammalian Gene Amplification and Sets Boundaries to Early AmpliconsCell, 1997
- Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells.Genes & Development, 1993
- Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells.Journal of Cell Biology, 1991
- Regulation of de novo and salvage pathways in chemotherapyAdvances in Enzyme Regulation, 1991